Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 14 hours 5 min ago

Opinion: ALS Is Not a Singular Disease. Stop Treating It Like One

Mon, 03/25/2024 - 02:00
Opinion: ALS Is Not a Singular Disease. Stop Treating It Like One 3/25/2024

FDA Approves Third Duchenne Muscular Dystrophy Treatment in Nine Months

Fri, 03/22/2024 - 02:00
FDA Approves Third Duchenne Muscular Dystrophy Treatment in Nine Months 3/22/2024

Medicare to Cover Novo’s Weight-Loss Drug Wegovy for Patients with Heart Disease

Fri, 03/22/2024 - 02:00
Medicare to Cover Novo’s Weight-Loss Drug Wegovy for Patients with Heart Disease 3/22/2024

Eledon’s Antibody Aids First Gene-Edited, Pig-to-Human Kidney Transplant

Fri, 03/22/2024 - 02:00
Eledon’s Antibody Aids First Gene-Edited, Pig-to-Human Kidney Transplant 3/22/2024

Roche’s IL-6 Blocker Clears Phase III Bar, Still Falls Short of Expectations

Fri, 03/22/2024 - 02:00
Roche’s IL-6 Blocker Clears Phase III Bar, Still Falls Short of Expectations 3/22/2024

The Time Has Come to Make Weight-Loss Drugs Available to Those Who Need Them

Fri, 03/22/2024 - 02:00
The Time Has Come to Make Weight-Loss Drugs Available to Those Who Need Them 3/22/2024

Bayer’s Prostate Cancer Drug Nubeqa on Track to Generate Blockbuster Sales in 2024

Fri, 03/22/2024 - 02:00
Bayer’s Prostate Cancer Drug Nubeqa on Track to Generate Blockbuster Sales in 2024 3/22/2024

Merck’s Keytruda Continues NSCLC Losing Streak with Phase III Flop

Thu, 03/21/2024 - 02:00
Merck’s Keytruda Continues NSCLC Losing Streak with Phase III Flop 3/21/2024

Mirador Launches with $400M in Funding, Targets Precision Medicines

Thu, 03/21/2024 - 02:00
Mirador Launches with $400M in Funding, Targets Precision Medicines 3/21/2024

Medicare Likely to Negotiate Prices for Obesity Drugs in Next Few Years: CBO

Thu, 03/21/2024 - 02:00
Medicare Likely to Negotiate Prices for Obesity Drugs in Next Few Years: CBO 3/21/2024

Money Talk: Salary Trends and Raises

Thu, 03/21/2024 - 02:00
Money Talk: Salary Trends and Raises 3/21/2024

Bayer Eliminates Nearly Half of Its Executive Positions in Major Overhaul

Thu, 03/21/2024 - 02:00
Bayer Eliminates Nearly Half of Its Executive Positions in Major Overhaul 3/21/2024

Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to Drug

Thu, 03/21/2024 - 02:00
Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to Drug 3/21/2024

Capstan Secures $175M Oversubscribed Series B with Backing from J&J, Bayer and BMS

Thu, 03/21/2024 - 02:00
Capstan Secures $175M Oversubscribed Series B with Backing from J&J, Bayer and BMS 3/21/2024

New Graduates Struggle in Current Biopharma Job Market

Thu, 03/21/2024 - 02:00
New Graduates Struggle in Current Biopharma Job Market 3/21/2024

Top 5 Remote Quality-Control Jobs

Thu, 03/21/2024 - 02:00
Top 5 Remote Quality-Control Jobs 3/21/2024

Orchard Sets $4.25M US Price for Gene Therapy Lenmeldy on Heels of Approval

Wed, 03/20/2024 - 02:00
Orchard Sets $4.25M US Price for Gene Therapy Lenmeldy on Heels of Approval 3/20/2024

BMS Racks Up Phase III Win in Liver Cancer Targeted by AstraZeneca and Roche

Wed, 03/20/2024 - 02:00
BMS Racks Up Phase III Win in Liver Cancer Targeted by AstraZeneca and Roche 3/20/2024

Lonza to Buy Roche Biologics Manufacturing Site in California for $1.2B

Wed, 03/20/2024 - 02:00
Lonza to Buy Roche Biologics Manufacturing Site in California for $1.2B 3/20/2024

Clasp Emerges with $150M Series A Financing to Advance T Cell Engagers

Wed, 03/20/2024 - 02:00
Clasp Emerges with $150M Series A Financing to Advance T Cell Engagers 3/20/2024